Defining the moribund condition as an experimental endpoint for animal research.
about
Extracorporeal Life Support Increases Survival After Prolonged Ventricular Fibrillation Cardiac Arrest in the Rat.Acute phase response in animals: a review.Use of a body condition score technique to assess health status in a rat model of polycystic kidney disease.Surface hypothermia predicts murine mortality in the intragastric Vibrio vulnificus infection modelIdentification of markers for imminent death in mice used in longevity and aging researchHow "humane" is your endpoint? Refining the science-driven approach for termination of animal studies of chronic infection.Welfare issues of genetically modified animals.New insights into the methodology of L-arginine-induced acute pancreatitis.Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis.Non-invasive technology that improves cardiac function after experimental myocardial infarction: Whole Body Periodic Acceleration (pGz).Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c miceProtective Effects of Hong Shan Capsule against Lethal Total-Body Irradiation-Induced Damage in Wistar Rats.Health Evaluation of Experimental Laboratory MiceThe Mixture of Salvianolic Acids from Salvia miltiorrhiza and Total Flavonoids from Anemarrhena asphodeloides Attenuate Sulfur Mustard-Induced InjuryEstablishing an appropriate period of acclimatization following transportation of laboratory animals.Clofazimine Biocrystal Accumulation in Macrophages Upregulates Interleukin 1 Receptor Antagonist Production To Induce a Systemic Anti-Inflammatory StateWeight loss and reduced body temperature determine humane endpoints in a mouse model of ocular herpesvirus infectionPredictive observation-based endpoint criteria for mice receiving total body irradiationModeling sepsis in the laboratory: merging sound science with animal well-beingEndpoints for mouse abdominal tumor models: refinement of current criteria.Small-Volume Adenosine, Lidocaine, and Mg2+ 4-Hour Infusion Leads to 88% Survival after 6 Days of Experimental Sepsis in the Rat without Antibiotics.Hypothermic endpoint for an intranasal invasive pulmonary aspergillosis mouse modelAnimal models of herpes simplex virus immunity and pathogenesis.A two-component system that controls the expression of pneumococcal surface antigen A (PsaA) and regulates virulence and resistance to oxidative stress in Streptococcus pneumoniae.Survival variability of controls and definition of imaging endpoints for longitudinal follow-up of pancreatic ductal adenocarcinoma in rats.Considerations for Infectious Disease Research Studies Using Animals.MASM, a Matrine Derivative, Offers Radioprotection by Modulating Lethal Total-Body Irradiation-Induced Multiple Signaling Pathways in Wistar Rats.Institutional Animal Care and Use Committee Considerations Regarding the Use of Virus-Induced Carcinogenesis and Oncolytic Viral Models.Endpoint refinement for total body irradiation of C57BL/6 mice.Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
P2860
Q30491829-A38C39C8-FA67-448E-9585-1C479F89F8B0Q33560307-E4E4631C-D294-4D25-95A0-9E52151F50DDQ33755133-2AB6A798-B675-4795-A8E3-F093B3F9D8C5Q33814441-83385461-793D-4B3E-9BAA-D0197A6593ACQ33880081-6F02C896-B3F3-41E8-A551-69D0F01D2664Q34139921-A2B54296-8572-4F01-87D3-C5E2F7E5E37BQ34578774-6D90FB25-5A20-490F-B46A-F125231E6DFBQ35092381-99930EC7-21FA-47DA-8771-A52AE8AEACAAQ35106279-0A90D762-A2E6-4D74-B97F-A62102ADA2C0Q35217259-93BB969D-6A56-4045-B526-15FC75BC4D4DQ35608714-E3A3CC6C-5310-4244-A6E4-5C5BFAF6A512Q36088649-4E8BCEDB-A8C6-42C8-80BC-160640913672Q36102497-5EDB4959-C55A-46DC-AB03-5E85D957E054Q36247434-DD567758-6F11-4AD3-BDB3-2BC523D7D996Q36590437-84FDA822-437C-42F3-B56E-0A843BD68D1BQ36933396-DCA93435-81CA-405F-A981-D5AC4E2CEB45Q36949116-88646FB5-7A9B-408B-B38D-BCD75C2519C8Q37113805-17245CB8-A28F-4CD1-823C-469BA3031539Q37181895-5C39EE36-1B28-4AD0-B250-74F378FFCE9FQ37322375-003B8774-F9BC-4F37-9584-9CC34EF9B356Q37396971-B0EF864A-81A0-497D-B23F-36450BA7F9E0Q37401043-FF9C23C8-6EF0-4E19-B9B2-96200AD15E4DQ38267269-80917F22-5478-47EA-BD1B-D81ED632C071Q38343874-993870C9-09D4-43AE-BAC1-7A529230582EQ38436041-419E1610-2E8C-4893-962A-56533AB76B8CQ38701962-9262B28B-C50F-4F47-B43F-093243DAF065Q39752942-809162FE-2F88-4BA7-84DD-44D6F4E63082Q40823356-A3B76220-8136-4C3D-80E4-EEA87FE509B9Q42154414-8EC19FDD-27EA-4FF3-B6B6-014740319964Q46201092-C6FC94FD-FB35-4ED1-87B8-0AE81FAE13E2
P2860
Defining the moribund condition as an experimental endpoint for animal research.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Defining the moribund condition as an experimental endpoint for animal research.
@ast
Defining the moribund condition as an experimental endpoint for animal research.
@en
Defining the moribund condition as an experimental endpoint for animal research.
@nl
type
label
Defining the moribund condition as an experimental endpoint for animal research.
@ast
Defining the moribund condition as an experimental endpoint for animal research.
@en
Defining the moribund condition as an experimental endpoint for animal research.
@nl
prefLabel
Defining the moribund condition as an experimental endpoint for animal research.
@ast
Defining the moribund condition as an experimental endpoint for animal research.
@en
Defining the moribund condition as an experimental endpoint for animal research.
@nl
P2860
P356
P1433
P1476
Defining the moribund condition as an experimental endpoint for animal research.
@en
P2093
P2860
P356
10.1093/ILAR.41.2.72
P577
2000-01-01T00:00:00Z